Spots Global Cancer Trial Database for personalized vaccine
Every month we try and update this database with for personalized vaccine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers | NCT03568058 | Advanced Cancer | personalized va... Pembrolizumab | 18 Years - | University of California, San Diego | |
| Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3) | NCT02808416 | Brain Cancer Neoplasm Metast... | Personalized ce... | 18 Years - 65 Years | Guangdong 999 Brain Hospital | |
| A Study of the Efficacy and Safety of RO7198457 in Combination With Atezolizumab Versus Atezolizumab Alone Following Adjuvant Platinum-Doublet Chemotherapy in Participants Who Are ctDNA Positive After Surgical Resection of Stage II-III Non-Small Cell Lung Cancer | NCT04267237 | Non-small Cell ... | Atezolizumab RO7198457 | 18 Years - | Hoffmann-La Roche | |
| A Study of the Efficacy and Safety of RO7198457 in Combination With Atezolizumab Versus Atezolizumab Alone Following Adjuvant Platinum-Doublet Chemotherapy in Participants Who Are ctDNA Positive After Surgical Resection of Stage II-III Non-Small Cell Lung Cancer | NCT04267237 | Non-small Cell ... | Atezolizumab RO7198457 | 18 Years - | Hoffmann-La Roche | |
| Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC) | NCT02709616 | Glioblastoma | Personalized ce... | 18 Years - 65 Years | Guangdong 999 Brain Hospital | |
| Personalized Immunotherapy in Adults With Upper Gastrointestinal Tract Cancers | NCT05153304 | Cancer of Gastr... | personalized va... Nivolumab | 18 Years - | University of California, San Diego | |
| Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma | NCT03223103 | Glioblastoma | Poly-ICLC Tumor Treating ... Peptides | 18 Years - | Albert Einstein College of Medicine | |
| A Personal Cancer Vaccine (NEO-PV-01) and APX005M or Ipilimumab With Nivolumab in Patients With Advanced Melanoma | NCT03597282 | Metastatic Mela... | NEO-PV-01 Nivolumab Adjuvant APX005M ipilimumab | 18 Years - | BioNTech SE | |
| Personalized Immunotherapy in Adults With Upper Gastrointestinal Tract Cancers | NCT05153304 | Cancer of Gastr... | personalized va... Nivolumab | 18 Years - | University of California, San Diego | |
| Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers | NCT03568058 | Advanced Cancer | personalized va... Pembrolizumab | 18 Years - | University of California, San Diego | |
| Safety and Immunogenicity of Personalized Genomic Vaccine to Treat Malignancies | NCT02721043 | Solid Tumors | Peptides Poly-ICLC Lenalidomide | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Safety and Immunogenicity of Personalized Genomic Vaccine to Treat Malignancies | NCT02721043 | Solid Tumors | Peptides Poly-ICLC Lenalidomide | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC) | NCT02709616 | Glioblastoma | Personalized ce... | 18 Years - 65 Years | Guangdong 999 Brain Hospital | |
| Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3) | NCT02808416 | Brain Cancer Neoplasm Metast... | Personalized ce... | 18 Years - 65 Years | Guangdong 999 Brain Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
